Team Australia is inviting Australian biotechnology, pharmaceutical, clinical trials and investment-focused companies to join the Team Australia delegation to BIO-Europe 2026 in Cologne, Germany from 9–11 November 2026. BIO-Europe is Europe's largest conference for the global biotechnology industry, bringing together biotechnology companies, pharmaceutical firms, investors and service providers from around the world. The event is projected to host over 8,000 participants from 60 countries, creating exceptional opportunities for industry engagement.

Delegates will benefit from access and branded presence at the Team Australia stand, feature in the Australian Companies Directory and targeted marketing campaign. Team Australia delegates will benefit from an extended Early Bird registration date to 31 August and preferential Early Bird rates of 15% (discount codes will be provided). After 31 August, a 15% discount will apply on whatever the rate is at the time of registration. The discount code will work on all registration types, except for Young Innovator, and cannot be applied retrospectively. 

Beyond BIO-Europe 2026, Austrade will facilitate two targeted seminars across Europe, providing a platform for deeper engagement with senior executives from the life sciences sector. The delegation is being delivered through the Australian Clinical Trials Initiative (ACTI) and supported by the Accessing New Markets Initiative (ANMI).

To express your interest in joining Team Australia at BIO-Europe 2026 and the associated seminars, complete the EOI form and select BIO-Europe 2026.

Program

Seminar Berlin

Expand your life sciences footprint in Germany

Following BIO-Europe 2026 in Cologne, Austrade invites Australian life sciences and clinical trials supply chain companies to join an exclusive business engagement program in Berlin, Germany on 12 November 2026.

Designed specifically for Australian companies looking to grow their presence in Europe, this program will connect you with key German biotech, pharmaceutical, research, and clinical trials stakeholders through targeted networking and business development opportunities.

Why join?

• Connect with potential customers, partners and collaborators.
• Showcase your capabilities to decision-makers across Germany’s life sciences ecosystem.
• Gain valuable market insights and strengthen your understanding of the German landscape.
• Build relationships that can support long-term commercial opportunities in one of Europe’s leading life sciences markets.

Take advantage of this opportunity to extend the value of your BIO-Europe visit and accelerate your business development in Germany.

Seminar at London Life Sciences Week 2026 (Seminar London)

Austrade invites Australian clinical trials service providers to join an exclusive industry seminar at Australia House, London, connecting Australian organisations with leading UK and international biotech, pharmaceutical, and life sciences stakeholders.

Held as part of London Life Sciences Week, when the global life sciences community gathers in London for a week of industry events, and scheduled back-to-back with BIO Europe in Cologne, the seminar offers a unique opportunity to maximise your European business development activities.

As one of the world's leading centres for drug discovery, biotechnology innovation, and life sciences R&D, the UK presents significant opportunities for Australian providers to showcase their capabilities, engage directly with decision makers responsible for clinical development and research outsourcing, build relationships with potential customers, partners, and collaborators, and explore commercial opportunities across the UK and broader European life sciences markets. Take advantage of this opportunity to position your organisation as a partner of choice for global clinical development programs and highlight the strengths of Australia's world class clinical trials ecosystem.

Why you should attend

By participating in BIO-Europe 2026, you will gain access to one of the world's premier life sciences partnering events, providing direct engagement opportunities with leading biotechnology companies, pharmaceutical firms, venture capital investors, licensing professionals and service providers from Europe, North America and Asia.

Europe remains one of the world's largest biotechnology and pharmaceutical markets, with strong demand for innovative therapeutics, clinical development capabilities and research partnerships. The EU’s life sciences sector is valued at more than €1.5 trillion and is home to 15% of the world’s top life sciences companies. Europe increasingly looks to Australia as a high-quality partner recognised for its efficient regulatory system, world-class and cost-effective clinical research, and competitive R&D environment. For Australian organisations, BIO-Europe provides a valuable opportunity to showcase capabilities, identify commercial partners, engage with investors and explore pathways into European markets.

As part of the Team Australia delegation, participants will benefit from a coordinated national presence that promotes Australia's strengths across biotechnology, drug development and clinical trials. Austrade's network throughout Europe can also provide market intelligence, introductions and practical support to help organisations maximise opportunities before, during and after the event.

Participant cost

There is no participation fee for companies joining the Team Australia delegation and pavilion at BIO-Europe 2026, enabled by Austrade’s investment through the Accessing New Markets Initiative (ANMI) and a partnership with state governments under a Team Australia approach.

Companies wishing to participate as speakers as part of the BIO-Europe 2026 speaking panels will be charged A$1,000 per company. 

Companies wishing to participate in either of the following seminars will also be charged A$1,000 per company, per event:

• Seminar Berlin
• Seminar London

Travel and accommodation remain the responsibility of participating companies.

Contact us

If you would like further information, please contact the Health Team at health@austrade.gov.au. Alternatively, you can contact the two key personnel below: